Endothelial dysfunction biomarker, endothelial cell-specific molecule-1, and pediatric metabolic syndrome

HALICI I., Palabiyik S. S., Guducu-Tufekci F., OZBEK-BILGIN A., CAYIR A.

PEDIATRICS INTERNATIONAL, cilt.58, sa.11, ss.1124-1129, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 58 Sayı: 11
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1111/ped.12989
  • Dergi Adı: PEDIATRICS INTERNATIONAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1124-1129
  • Anahtar Kelimeler: endocan, endothelial dysfunction, enzyme-linked immunosorbent assay, metabolic syndrome, pediatric, CARDIOVASCULAR RISK-FACTORS, HOMEOSTASIS MODEL ASSESSMENT, C-REACTIVE PROTEIN, INSULIN-RESISTANCE, ENDOCAN LEVELS, ADIPOSE-TISSUE, YOUNG-ADULTS, CHILDHOOD, CHILDREN, OBESE
  • Atatürk Üniversitesi Adresli: Evet

Özet

BackgroundThe aim of this study was to compare serum endothelial cell-specific molecule-1 (endocan) in pediatric patients with metabolic syndrome (MetS) and in healthy children, and to determine whether it can be used as an indicator of endothelium damage-induced complications in pediatric MetS patients.